Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
6.04M
-
Shares change
-
+297K
-
Total reported value, excl. options
-
$47.2M
-
Value change
-
+$475K
-
Number of buys
-
27
-
Number of sells
-
-16
-
Price
-
$7.81
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q4 2018
49 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q4 2018.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.04M shares
of 13.8M outstanding shares and own 43.63% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (1.95M shares), NEA Management Company, LLC (1.56M shares), Vanguard Group Inc (251K shares), RENAISSANCE TECHNOLOGIES LLC (240K shares), EAM Investors, LLC (196K shares), PERKINS CAPITAL MANAGEMENT INC (175K shares), INGALLS & SNYDER LLC (159K shares), Schonfeld Strategic Advisors LLC (139K shares), BlackRock Inc. (125K shares), and CADENCE CAPITAL MANAGEMENT LLC (123K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.